Solis Mammography is using artificial intelligence software to identify heart disease in women who come in for their yearly mammogram.
The new screening is called Mammo+Heart, and uses U.S. Food and Drug Administration-cleared software to detect the presence or absence of breast arterial calcification, a calcium building in the breast’s arteries.
The details
Chief Medical Officer Chirag Parghi said research shows women with breast arterial calcification have an increased risk of heart disease or stroke and the new technology provides insight into a woman’s cardiovascular risk. He said the goal of the screening is to get women who are at risk the additional tools they need.














